These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12357381)

  • 1. Expression of CD133 on a human cell line lacking CD34.
    Delfini C; Centis F; Falzetti F; Tabilio A
    Leukemia; 2002 Oct; 16(10):2174-5; author reply 2175. PubMed ID: 12357381
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of CD133 (AC133) and CD90 expression analysis for acute leukemia immunophenotyping.
    Wuchter C; Ratei R; Spahn G; Schoch C; Harbott J; Schnittger S; Haferlach T; Creutzig U; Sperling C; Karawajew L; Ludwig WD
    Haematologica; 2001 Feb; 86(2):154-61. PubMed ID: 11224484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic purging of autologous peripheral blood stem cell products based on CD34 and CD133 expression can be effectively and safely applied in half of the acute myeloid leukemia patients.
    Feller N; van der Pol MA; Waaijman T; Weijers GW; Westra G; Ossenkoppele GJ; Schuurhuis GJ
    Clin Cancer Res; 2005 Jul; 11(13):4793-801. PubMed ID: 16000576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AC133+ G0 cells from cord blood show a high incidence of long-term culture-initiating cells and a capacity for more than 100 million-fold amplification of colony-forming cells in vitro.
    Summers YJ; Heyworth CM; de Wynter EA; Hart CA; Chang J; Testa NG
    Stem Cells; 2004; 22(5):704-15. PubMed ID: 15342935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collection and analysis of hematopoietic progenitor cells from cynomolgus macaques (Macaca fascicularis): assessment of cross-reacting monoclonal antibodies.
    Shibata H; Hanazono Y; Ageyama N; Nagashima T; Ueda Y; Hasegawa M; Ozawa K; Yoshikawa Y; Terao K
    Am J Primatol; 2003 Sep; 61(1):3-12. PubMed ID: 12966515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of proliferative potential and clonogenicity of MACS-immunomagnetic isolated CD34+ and CD133+ blood stem cells derived from a single donor.
    Freund D; Oswald J; Feldmann S; Ehninger G; Corbeil D; Bornhäuser M
    Cell Prolif; 2006 Aug; 39(4):325-32. PubMed ID: 16872366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allostimulatory activity of CD133+ hematopoietic cells.
    Patel P; Abbasian J; Mahmud D; Mahmud N; Horsthemke PM; Chunduri S; Rondelli D
    Bone Marrow Transplant; 2013 May; 48(5):742-4. PubMed ID: 23165492
    [No Abstract]   [Full Text] [Related]  

  • 8. Rapid reconstitution of dendritic cells after allogeneic transplantation of CD133+ selected hematopoietic stem cells.
    Bornhäuser M; Eger L; Oelschlaegel U; Auffermann-Gretzinger S; Kiani A; Schetelig J; Illmer T; Schaich M; Corbeil D; Thiede C; Ehninger G
    Leukemia; 2005 Jan; 19(1):161-5. PubMed ID: 15510205
    [No Abstract]   [Full Text] [Related]  

  • 9. Expression, regulation and function of AC133, a putative cell surface marker of primitive human haematopoietic cells.
    Majka M; Ratajczak J; Machalinski B; Carter A; Pizzini D; Wasik MA; Gewirtz AM; Ratajczak MZ
    Folia Histochem Cytobiol; 2000; 38(2):53-63. PubMed ID: 10833669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of AC133 vs. CD34 in acute childhood leukemias].
    Ebener U; Brinkmann A; Zotova V; Niegemann E; Wehner S
    Klin Padiatr; 2000; 212(3):90-8. PubMed ID: 10916777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloid differentiation and maturation of SCF+IL-3+IL-11 expanded AC133+/CD34+ cells selected from high-risk breast cancer patients.
    Filip S; Vávrová J; Vokurková D; Bláha M; Vanásek J
    Neoplasma; 2000; 47(2):73-80. PubMed ID: 10985471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD133-2 (AC141) expression analysis in acute leukemia immunophenotyping in correlation to CD34 and P-glycoprotein.
    Guenova M; Balatzenko G
    Hematology; 2008 Jun; 13(3):137-41. PubMed ID: 18702870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A functional hierarchy among the CD34+ hematopoietic cells based on in vitro proliferative and differentiative potential of AC133+CD34(bright) and AC133(dim/)-CD34+ human cord blood cells.
    Goussetis E; Theodosaki M; Paterakis G; Peristeri J; Petropoulos D; Kitra V; Papassarandis C; Graphakos S
    J Hematother Stem Cell Res; 2000 Dec; 9(6):827-40. PubMed ID: 11177594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cells.
    Kobari L; Giarratana MC; Pflumio F; Izac B; Coulombel L; Douay L
    J Hematother Stem Cell Res; 2001 Apr; 10(2):273-81. PubMed ID: 11359674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro proliferation potential of AC133 positive cells in peripheral blood.
    Matsumoto K; Yasui K; Yamashita N; Horie Y; Yamada T; Tani Y; Shibata H; Nakano T
    Stem Cells; 2000; 18(3):196-203. PubMed ID: 10840073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of haematopoietic stem cell markers, CD133 and CD34 on human corneal keratocytes.
    Perrella G; Brusini P; Spelat R; Hossain P; Hopkinson A; Dua HS
    Br J Ophthalmol; 2007 Jan; 91(1):94-9. PubMed ID: 16956910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on the dynamics of biological characteristics of CD133+ cells from human umbilical cord blood during short-term culture].
    Hao SG; Sun GL; Wu WL; Wu YL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):569-75. PubMed ID: 14706136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viable CD34+/CD133+ blood progenitor cell dose as a predictor of haematopoietic engraftment in multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation.
    Hicks C; Wong R; Manoharan A; Kwan YL
    Ann Hematol; 2007 Aug; 86(8):591-8. PubMed ID: 17492259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous CD34+ and CD133+ stem cells transplantation in patients with end stage liver disease.
    Salama H; Zekri AR; Bahnassy AA; Medhat E; Halim HA; Ahmed OS; Mohamed G; Al Alim SA; Sherif GM
    World J Gastroenterol; 2010 Nov; 16(42):5297-305. PubMed ID: 21072892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracoronary infusion of CD133+ and CD133-CD34+ selected autologous bone marrow progenitor cells in patients with chronic ischemic cardiomyopathy: cell isolation, adherence to the infarcted area, and body distribution.
    Goussetis E; Manginas A; Koutelou M; Peristeri I; Theodosaki M; Kollaros N; Leontiadis E; Theodorakos A; Paterakis G; Karatasakis G; Cokkinos DV; Graphakos S
    Stem Cells; 2006 Oct; 24(10):2279-83. PubMed ID: 16794269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.